MICROBIOME BIOTECH FIRM GENOME & COMPANY AWAIT FINAL WORD BEFORE IPO ON KOSDAQ

• Still waiting to go public with its initial public offering (IPO) at tech-intensive KOSDAQ later this year, Genome & Company laid out the biotech firm's various business models and oncoming visions focusing on its microbiome-based immuno-oncology expertise at its IR event on Thurs...